First Hawaiian Bank Increases Position in Smith & Nephew plc (NYSE:SNN)

First Hawaiian Bank increased its stake in Smith & Nephew plc (NYSE:SNNFree Report) by 15.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,250 shares of the medical equipment provider’s stock after purchasing an additional 1,466 shares during the quarter. First Hawaiian Bank’s holdings in Smith & Nephew were worth $307,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Bessemer Group Inc. increased its holdings in Smith & Nephew by 397.3% during the 4th quarter. Bessemer Group Inc. now owns 920 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 735 shares in the last quarter. Allworth Financial LP increased its holdings in Smith & Nephew by 1,566.2% during the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 1,065 shares in the last quarter. Clear Street Markets LLC purchased a new position in Smith & Nephew during the 4th quarter valued at about $38,000. Thomas J. Herzfeld Advisors Inc. increased its holdings in Smith & Nephew by 124.1% during the 2nd quarter. Thomas J. Herzfeld Advisors Inc. now owns 1,838 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 1,018 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in Smith & Nephew by 18,258.3% during the 3rd quarter. Tower Research Capital LLC TRC now owns 2,203 shares of the medical equipment provider’s stock valued at $55,000 after acquiring an additional 2,191 shares in the last quarter. 8.65% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SNN has been the subject of several recent research reports. Barclays upgraded shares of Smith & Nephew from an “underweight” rating to an “equal weight” rating in a report on Tuesday, November 28th. StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 15th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Smith & Nephew has a consensus rating of “Moderate Buy”.

View Our Latest Stock Analysis on SNN

Smith & Nephew Stock Down 1.9 %

Smith & Nephew stock opened at $26.42 on Thursday. Smith & Nephew plc has a 12-month low of $21.52 and a 12-month high of $33.08. The firm’s 50-day moving average is $27.70 and its two-hundred day moving average is $26.10. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44.

Smith & Nephew Announces Dividend

The company also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be paid a dividend of $0.462 per share. The ex-dividend date of this dividend is Monday, April 1st. This represents a dividend yield of 2.8%.

Smith & Nephew Profile

(Free Report)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Read More

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.